Zhitong Financial APP learned that on August 8, the Securities Regulatory Commission announced the progress of the "approval of overseas initial public offering of shares (including common shares, preferred shares and other derivative forms of shares and stocks)" of Guangzhou Yinming Biopharmaceutical Technology Co., Ltd., and the progress has reached the stage of receiving materials.
证监会：广州因明生物医药科技股份有限公司境外IPO申请已获接收材料
CSRC: materials received for overseas IPO application of Guangzhou Yinming Biopharmaceutical Technology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.